Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Digoxin-quinidine interaction in patients with chronic renal failure.

View through CrossRef
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure. Quinidine reduced the total body clearance of digoxin from 1.87 to 1.06 l/hour (p less than 0.001), and prolonged the digoxin half-life of elimination from 5.20 to 9.61 days (p less than 0.01). The digoxin volume of distribution was unchanged. Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin. The mean trough serum concentrations of quinidine ranged from 1.0 to 3.0 micrograms/ml. We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.
Title: Digoxin-quinidine interaction in patients with chronic renal failure.
Description:
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure.
Quinidine reduced the total body clearance of digoxin from 1.
87 to 1.
06 l/hour (p less than 0.
001), and prolonged the digoxin half-life of elimination from 5.
20 to 9.
61 days (p less than 0.
01).
The digoxin volume of distribution was unchanged.
Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin.
The mean trough serum concentrations of quinidine ranged from 1.
0 to 3.
0 micrograms/ml.
We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are rec...
Radioimmunoassay of Digoxin—Interference by Digitoxin
Radioimmunoassay of Digoxin—Interference by Digitoxin
Abstract Digitoxin interference with radioimmunoassay of digoxin may present a problem in determining digoxin concentrations in the serum of patients treated with di...
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
Objective Study the clinical efficacy and safety of transplacental digoxin therapy for foetal heart failure. Investigate the evaluation and treatment guiding valu...
Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure
Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure
To assess the effect of oral digoxin on left ventricular systolic function in elderly patients, radionuclide angiography was performed on 20 patients 74 years old or older before a...
Digoxin
Digoxin
Abstract This chapter focuses on digoxin, one of many cardiac glycosides (also known as cardiotonic steroids) that have been studied to varying degrees over the year...
Digoxin: Review of Current Laboratory Practice and Considerations
Digoxin: Review of Current Laboratory Practice and Considerations
Digoxin is a drug used for its effects on the heart, particularly its effect on rate and strength of contraction. Levels are particularly useful in clinical practice owing to its n...
Digoxin Therapy in Heart Failure and Atrial Fibrillation: A Pharmacotherapeutic Review for Pharmacists
Digoxin Therapy in Heart Failure and Atrial Fibrillation: A Pharmacotherapeutic Review for Pharmacists
Background: Digoxin, a cardiac glycoside derived from Digitalis lanata, has been used for decades in managing heart failure and atrial fibrillation. Despite its historical prominen...

Back to Top